These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 904549
1. [Treatment of primary hyperlipoproteinemia type IIb and IV. Comparison of the lipid lowering effect of phenformin, clofibrate, and a combination of both (author's transl)]. Koschinsky T, Lenhard P, Gries FA, Vogelberg KH, Wolfram G, Lang PD, Vollmar J. Med Klin; 1977 Sep 23; 72(38):1537-43. PubMed ID: 904549 [Abstract] [Full Text] [Related]
2. [Treatment of primary hyperlipoproteinemias of type IIB and IV with butylbiguanide and clofibrate (author's transl)]. Koschinsky T, Gries FA, Schwandt P, Weisweiler P, Hansen W, Nijssen J, Beckmann R. MMW Munch Med Wochenschr; 1977 May 20; 119(20):701-4. PubMed ID: 195201 [Abstract] [Full Text] [Related]
3. [Combination of clofibrate and phenformin in the treatment of endogenous hypertriglyceridaemia (author's transl)]. Vogelberg KH. Dtsch Med Wochenschr; 1976 Dec 17; 101(51):1868-71. PubMed ID: 1001205 [Abstract] [Full Text] [Related]
4. [Comparison between combination therapy with clofibrate and beta-pyridylcarbinol and clofibrate monotherapy (author's transl]. Mordasini R, Müller A, Klose G, Middelhoff G, Augustin J, Haase W, Greten H. MMW Munch Med Wochenschr; 1978 Apr 14; 120(15):525-8. PubMed ID: 206826 [Abstract] [Full Text] [Related]
5. [Comparison of clofibrate and bezafibrate in type IIa and type IIb hyperlipoproteinemia]. Arntz HR, Klemens UH, Vollmar LJ, Lang PD. Med Klin; 1978 Dec 08; 73(49):1731-7. PubMed ID: 723760 [Abstract] [Full Text] [Related]
6. [Treatment of hyperlipoproteinaemia types IIa, IIb, IV and V with a combination of clofibrate and inositol nicotinate (author's transl)]. Wilke H, Frahm H. Dtsch Med Wochenschr; 1976 Mar 12; 101(11):401-5. PubMed ID: 1253701 [Abstract] [Full Text] [Related]
7. [The effect of etofibrate on serum cholesterol and triglycerides (author's transl)]. Dimroth H. Med Klin; 1979 Jun 01; 74(22):875-6. PubMed ID: 470785 [Abstract] [Full Text] [Related]
8. [The lipid reducing action of phenformin in primary type IV hyperlipoproteinaemia (author's transl)]. Lang PD, Vollmar J, Klemens UH, von Löwis P, Gries FA, Koschinsky T, Huth K, Pilz E, Schlierf G, Kremer GJ, Lenhart P, Schwandt P, Hammerl H, Studlar M. Dtsch Med Wochenschr; 1973 Nov 30; 98(48):2280-6. PubMed ID: 4762828 [No Abstract] [Full Text] [Related]
9. Effect of calcium p-chlorphenoxyisobutyrate and calcium carbonate on plasma lipids and lipoproteins of patients with hyperlipoproteinaemia. Koskinen P, Inkovaara J, Ala-Kaila K, Salo M, Nikkari T. Ann Clin Res; 1977 Dec 30; 9(6):335-41. PubMed ID: 356720 [Abstract] [Full Text] [Related]
10. [Clofibrate treatment of diabetics with hyperproteinemias (author's transl)]. Jung W, Kremer GJ, Müller D. MMW Munch Med Wochenschr; 1975 Oct 31; 117(44):1783-6. PubMed ID: 171564 [Abstract] [Full Text] [Related]
14. [Treatment of hyperlipidaemia. A comparison of the efficacy of clofibrate and beta-pyridylcarbinol (author's transl)]. Wolfram G, Keller C, Kilani S, Zöllner N. Dtsch Med Wochenschr; 1976 Jan 16; 101(3):76-81. PubMed ID: 1245160 [Abstract] [Full Text] [Related]
19. Effect of ursodeoxycholic acid on bile supersaturated with cholesterol in patients pretreated with clofibrate. Kutz K, Schulte A. Z Gastroenterol; 1981 May 16; 19(5):231-6. PubMed ID: 7257479 [Abstract] [Full Text] [Related]
20. [Effect of etofylline clofibrate on the composition of lipoproteins in hyperlipidaemia type IIb and IV (author's transl)]. Ditschuneit HH, Hutt V, Klör HU, Ditschuneit H. Arzneimittelforschung; 1980 May 16; 30(11b):2063-7. PubMed ID: 7194061 [Abstract] [Full Text] [Related] Page: [Next] [New Search]